Wells Fargo analyst Elyse Greenspan raised the firm’s price target on MetLife (MET) to $97 from $94 and keeps an Overweight rating on the shares. Into quarterly results for the insurance space, the firm says the focus should be on pricing, loss trend, and reserves for P&C companies, organic and margin for brokers, and sales/capital/guidance for life companies.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET: